Record 3997 View: Standard | Glossary HistCite Guide |
Author(s): Rybak YE; McNeely HE; Mackenzie BE; Jain UR; Levitan RD
Title: An open trial of light therapy in adult attention-deficit/hyperactivity disorder
Source: JOURNAL OF CLINICAL PSYCHIATRY 67 (10): 1527-1535
Date: 2006 OCT
Document Type: Journal : Article
Language: English
Comment:
Address: Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON, Canada.
Univ Toronto, Dept Psychiat, Toronto, ON, Canada. Reprint: Rybak, YE, Univ Western Ontario, London Hlth Sci Ctr, Dept Psychiat,
357 S St, London, ON N6A 4G5, Canada. E-mail: irybak@uwo.ca
Abstract: Objective: In adults with attention-deficit/hyperactivity disorder (ADHD), a delayed sleep/activity rhythm and/or seasonal mood symptoms may contribute significantly to core pathology and disability. This study examined whether a chronobiologically based treatment, i.e., morning bright light therapy (LT), might have utility as an adjunctive treatment for adult ADHD in the fall/winter period. Method: Twenty-nine adults with DSM-IV ADHD were administered a standard 3-week open trial of LT during the fall or winter months. Primary outcome measures included percentage reduction on the Brown Adult ADD Scale and the Conners' Adult ADHD Scale. Secondary measures were decrease in depression scores according to the Structured Interview Guide for the Hamilton Depression Rating Scale, Seasonal Affective Disorder version; improvements on various neuropsychological tests; and shift toward an earlier circadian preference as measured by the Horne-Ostberg Morningness-Eveningness questionnaire. Regression analyses determined which variables at baseline best predicted improvement on a given outcome measure and which variables changed in parallel with one another. The study was conducted from November 2003 through February 2004. Results: Morning bright light therapy was associated with a significant decrease in both subjective and objective measures of core ADHD pathology, improved mood symptoms, and a significant phase advance in circadian preference. Multiple regression showed that the shift toward an earlier circadian preference with LT was the strongest predictor of improvement on both subjective and objective ADHD measures. Neither baseline global seasonality scores nor baseline depression scores strongly predicted LT effects on most measures of ADHD. Conclusion: These findings suggest that during the fall/winter period, LT may be a useful adjunct in many adults with ADHD. Strikingly, the strongest correlate of improvement in core ADHD pathology was a phase advance in circadian preference rather than alleviation of comorbid seasonal affective disorder, suggesting important clinical benefits of LT beyond the treatment of seasonal affective disorder.
Cited References: ARNSTEN AFT, 2005, BIOL PSYCHIAT, V57, P1377 BARKLEY RA, 2002, J ABNORM PSYCHOL, V111, P279 BIEDERMAN J, 2004, J CLIN PSYCHIAT S3, V65, P3 BLAIR JR, 1989, CLIN NEUROPSYCHOL, V3, P129 BROWN TE, 1996, ADD SCALES BROWN TE, 2001, ANN NY ACAD SCI, V931, P271 CHESSON AL, 1999, SLEEP, V22, P641 CONNERS CK, 1999, ADULT ADHD RATING SC CONNERS CK, 2000, CONTINUOUS PERFORMAN DAHL RE, 1991, J PEDIATR PSYCHOL, V16, P229 DIKMEN SS, 1999, J INT NEUROPSYCH SOC, V5, P346 FARAONE SV, 1998, BIOL PSYCHIAT, V44, P951 FIRST MB, 2002, STRUCTURED CLIN INTE, P337 GIBERTINI M, 1999, BIOL PSYCHOL, V50, P19 HORNE JA, 1976, INT J CHRONOBIOL, V4, P97 LAM RW, 1994, AM J PSYCHIAT, V151, P744 LAM RW, 2001, NEUROPSYCHOPHARMA S5, V25, PS97 LEVITAN RD, 1999, COMPR PSYCHIAT, V40, P261 LEVITAN RD, 2004, BIOL PSYCHIAT, V56, P665 LEVITAN RD, 2004, NEUROPSYCHOPHARMACOL, V29, P179 LEWY AJ, 1989, CHRONOBIOL INT, V6, P93 LEZAK MD, 2004, NEUROPSYCHOLOGICAL A MIRSKY AF, 2001, ANN NY ACAD SCI, V931, P17 MURRAY G, 2003, J AFFECT DISORDERS, V76, P15 NEUMEISTER A, 1998, ARCH GEN PSYCHIAT, V55, P524 NEUMEISTER A, 2001, PSYCHOL MED, V31, P1467 PARTONEN T, 1996, MED HYPOTHESES, V47, P191 ROSENTHAL NE, 1987, SEASONAL PATTERN ASS ROSENTHAL NE, 1995, AM J PSYCHIAT, V152, P1402 RYBAK YE, 2004, CHRONOBIOL INT, V21, P802 SILVER LB, 2000, CHILD ADOL PSYCH CL, V9, P511 TAILLARD J, 1999, J SLEEP RES, V8, P291 TERMAN JS, 2001, ARCH GEN PSYCHIAT, V58, P69 TERMAN M, 2005, CNS SPECTRUMS, V10, P647 TURNER DC, 2004, BIOL PSYCHIAT, V55, P1031 TUUNAINEN A, 2004, COCHRANE DB SYST REV, ARCD004050 WARD MF, 1993, AM J PSYCHIAT, V150, P1280 WASSERSTEIN J, 2005, J CLIN PSYCHOL, V61, P535 WEINBERG WA, 1990, J PEDIATR, V116, P720 WEISS M, 1999, ADHD ADULTHOOD WILLIAMS JBW, 1988, STRUCTURED INTERVIEW |